Publikace

Nalezené publikace: 69

F. I. Crespo, S. J. Mayora, J. B. De Sanctis, W. Y. Martínez, M. E. Zabaleta-Lanz, F. I. Toro, L. H. Deibis and A. H. García
"SARS-CoV-2 Infection in Venezuelan Pediatric Patients—A Single Center Prospective Observational Study",
BIOMEDICINES, vol. 11, iss. 5, pp. 1409, 2023.
IF = 4.757
K. Dvorakova Bendova, K. Krasulova, B. Neuzilova, M. Popper, P. Mlynarcik, K. Hajduova, Z. Novy, M. Hajduch and M. Petrik
"Positron Emission Tomography Imaging of Acinetobacter baumannii Infection: Comparison of Gallium-68 Labeled Siderophores",
ACS INFECTIOUS DISEASES, vol. 11, iss. 4, pp. 917-928, 2025.
IF = 4.5
A. H. García, S. J. Mayora, C. Medina, I. A. Belisario, W. Y. Martínez, F. I. Crespo and J. B. D. Sanctis
"Exploring Immune Responses to SARS-CoV-2: Insights from Sinopharm (BBIBP-CorV)-Vaccinated Individuals in a Group of Venezuelan Admixed Volunteers",
BIOMEDICINES, vol. 13, iss. 7, pp. 1550, 2025.
IF = 4.5
A. Ligasová and K. Koberna
"DNA Dyes—Highly Sensitive Reporters of Cell Quantification: Comparison with Other Cell Quantification Methods",
MOLECULES, vol. 26, iss. 18, pp. 5515, 2021.
IF = 4.411
J. B. De Sanctis, J. V. Garmendia, H. Duchová, V. Valentini, A. Puskasu, A. Kubíčková and M. Hajdúch
"Lck Function and Modulation: Immune Cytotoxic Response and Tumor Treatment More Than a Simple Event",
CANCERS, vol. 16, iss. 15, pp. 2630, 2024.
IF = 4.4
V. M. Velavalapalli, V. C. Maddipati, S. Gurská, N. Annadurai, B. Lišková, N. K. Katari, P. Džubák, M. Hajdúch, V. Das and R. Gundla
"Novel 5-Substituted Oxindole Derivatives as Bruton’s Tyrosine Kinase Inhibitors: Design, Synthesis, Docking, Molecular Dynamics Simulation, and Biological Evaluation",
ACS OMEGA, vol. 9, iss. 7, pp. 8067-8081, 2024.
IF = 4.3
V. Das, S. M. Modarres Mousavi, N. Annadurai, S. Sukur, F. Mehrnejad, S. Moradi, L. Malina, M. Kolaříková, V. Ranc, I. Frydrych, R. Kouřil, S. Hosseinkhani, M. Hajdúch and M. Nikkhah
"Hydrophobic residues in the α‐synuclein NAC domain drive seed‐competent fibril formation and are targeted by peptide inhibitors",
THE FEBS JOURNAL, vol. 293, iss. 1, pp. 134-155, 2026.
IF = 4.2
J. V. Garmendia, C. V. De Sanctis, M. Hajdúch and J. B. De Sanctis
"Microbiota and Recurrent Pregnancy Loss (RPL); More than a Simple Connection",
MICROORGANISMS, vol. 12, iss. 8, pp. 1641, 2024.
IF = 4.2
I. Frydrych, J. Řehulka, L. Slavíková, J. Hodoň, J. Pokorný, V. Šidová, M. Medvedíková, H. Slavík, P. Polishchuk, T. Oždian, J. Vrbková, J. Šarek, P. Džubák, M. Hajdúch and M. Urban
"Triterpenoid derivatives inhibit Gli-mediated transcription in human glioblastoma cell line via direct interaction with Gli1",
JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 301, iss. 9, pp. 110472, 2025.
IF = 4.1
Z. Spurná, P. Čapková, L. Punová, J. DuchoslavovÁ, D. Aleksijevic, P. Venháčová, J. Srovnal, J. Štellmachová, V. Curtisová, V. Bitnerová, J. Petřková, K. Kolaříková, M. Janíková, R. Kratochvílová, P. Vrtěl, R. Vodička, R. Vrtěl and J. Zapletalová
"Clinical-genetic analysis of selected genes involved in the development of the human skeleton in 128 Czech patients with suspected congenital skeletal abnormalities",
GENE, vol. 892, pp. 147881, 2024.
IF = 3.913
K. Hajduová, K. D. Bendová, M. Petřík, M. Benešová-Schäfer, M. Schäfer, M. Hajdúch and Z. Nový
"Paving the way for future PSMA inhibitors: insights from comparative preclinical evaluations of structure modifications",
EJNMMI RADIOPHARMACY AND CHEMISTRY, vol. 10, article no. 63, 2025.
IF = 3.7
J. Trommer, M. Ullrich, F. Reissig, S. A. Brühlmann, A. Nitt-Weber, Z. Novy, K. Hajduova, D. Kurfurstova, R. Hendrychova, J. Bouchal, M. Petrik, C. Neuber, W. Sihver, S. Stadlbauer, J. Pietzsch, M. Kreller, K. Kopka, C. Mamat and K. Zarschler
"It’s a match: use of the radionuclide theranostic pair 133La/225Ac for the radiopharmacological characterization of EGFR-targeted single-domain antibodies",
EJNMMI RADIOPHARMACY AND CHEMISTRY, vol. 10, article no. 31, 2025.
IF = 3.7
V. Das, L. Diomede, L. Malina, M. Mosconi and N. Annadurai
"Intrinsic aggregation and propagation of unmodified tau peptides: R2R3 as a minimal model system",
BIOPHYSICAL JOURNAL, vol. 124, iss. 14, pp. 2339-2346, 2025.
IF = 3.7
A. I. Suárez, K. E. Chávez, P. Martínez, J. Bubis, Z. Blanco, H. Ramírez, J. V. Garmendia, J. B. D. Sanctis, S. Gurská, P. Džubák, M. Hajdúch and J. E. Charris
"New 1,2,3‐Triazole Hybrids as Anticancer Agents: Design, Synthesis, Characterization, and In Silico Studies",
ChemMedChem, vol. 21, iss. 15, article no. e70425, 2026.
IF = 3.5
E. Schadich, D. Kaczorová, T. Béres, P. Džubák, M. Hajdúch, P. Tarkowski and S. Ćavar Zeljković
"Secondary metabolite profiles and anti‐SARS‐CoV‐2 activity of ethanolic extracts from nine genotypes of Cannabis sativa L.",
ARCHIV DER PHARMAZIE, vol. 358, iss. 1, e2400607, 2025.
IF = 3.5
G. Mudasani, N. K. Rampeesa, S. R. Anugu, P. Muddasani, S. Gurská, P. Džubák, M. Hajdúch, V. Das and R. Gundla
"Design, synthesis, and biological evaluation of novel azaspirooxindolinone derivatives as potent inhibitors of ITK and BTK-dependent cancers",
BIOORGANIC & MEDICINAL CHEMISTRY, vol. 121, pp. 118116, 2025.
IF = 3.5
R. R. Mudda, V. Basava, R. Gundla, R. Chennuru, S. Gurská, V. Das and N. K. Katari
"New molecular hybrids of spirochromanone and carbamide: Design, synthesis, docking and in vitro anticancer studies",
JOURNAL OF THE INDIAN CHEMICAL SOCIETY, vol. 102, iss. 12, pp. 102177, 2025.
IF = 3.4
C. P. Koraboina, V. C. Maddipati, N. Annadurai, S. Gurská, P. Džubák, M. Hajdúch, V. Das and R. Gundla
"Synthesis and Biological Evaluation of Oxindole Sulfonamide Derivatives as Bruton's Tyrosine Kinase Inhibitors**",
CHEMMEDCHEM, vol. 19, iss. 1, pp. e202300511, 2024.
IF = 3.4